1.
Ottaiano A, Capozzi M, De Divitiis C, De Stefano A, Botti G, Avallone A, et al. Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials. AO [Internet]. 2017 Mar. 4 [cited 2025 Feb. 17];56(3):499. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25125